Amrutanjan Health Care News

Amrutanjan FY26 PAT Rises 14%; Board Recommends Dividend

Amrutanjan Health Care reported FY26 PAT of INR 5,791.78 lakhs, revenue of INR 50,255.27 lakhs, Q4 EBITDA margin of 19.12%, and recommended a final dividend of INR 2.90 per share.

Amrutanjan FY26 PAT at INR 5,791.78 Lakhs; Operating Profits Rise 34%

Amrutanjan Health Care reported FY26 PAT of INR 5,791.78 lakhs, revenue from operations of INR 50,255.27 lakhs, and recommended a final dividend of INR 2.90 per share.

Amrutanjan Q4 FY26: Revenue 1.5B, EBITDA Margin 17.05%

Amrutanjan Health Care Q4 FY26: Revenue 1.5B Rupees vs 1.35B YoY, EBITDA 255M vs 177M YoY, EBITDA margin 17.05% vs 13.07% YoY, net profit 161M vs 152M YoY.

Amrutanjan FY26 PAT at INR 5,791.78 Lakhs; Board Appoints Directors

Amrutanjan Health Care reported FY26 PAT of INR 5,791.78 lakhs, revenue of INR 50,255.27 lakhs, operating profits up 34%, with new product launches and board director appointments.